| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $27.4M | — | +44.7% |
| SG&A Expense | $9.4M | — | +54.9% |
| Operating Income | -$36.8M | — | -47.2% |
| Pre-tax Income | -$33.9M | — | -39.2% |
| Income Tax | $0 | — | — |
| Net Income | -$33.9M | — | -39.2% |
| EPS (Basic) | -$0.59 | — | -11.3% |
| EPS (Diluted) | -$0.59 | — | -11.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $105.4M | -63.4% | +266.1% |
| Current Assets | $283.1M | -12.3% | +93.6% |
| Total Assets | $326.3M | -8.3% | +112.2% |
| Current Liabilities | $33.6M | -6.1% | +50.6% |
| Total Liabilities | $47.6M | -5.1% | +82.2% |
| Stockholders' Equity | $278.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$29.3M | — | -354.7% |
| Capital Expenditures | $5.1M | — | +471.6% |
| Investing Cash Flow | -$154.6M | — | -747.3% |
| Financing Cash Flow | $1.5M | — | +2820.6% |
| Free Cash Flow | -$34.4M | — | -369.0% |
| +118.3% |